215 related articles for article (PubMed ID: 22322857)
1. Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis.
Kerr E; Holohan C; McLaughlin KM; Majkut J; Dolan S; Redmond K; Riley J; McLaughlin K; Stasik I; Crudden M; Van Schaeybroeck S; Fenning C; O'Connor R; Kiely P; Sgobba M; Haigh D; Johnston PG; Longley DB
Cell Death Differ; 2012 Aug; 19(8):1317-27. PubMed ID: 22322857
[TBL] [Abstract][Full Text] [Related]
2. Vorinostat/SAHA-induced apoptosis in malignant mesothelioma is FLIP/caspase 8-dependent and HR23B-independent.
Hurwitz JL; Stasik I; Kerr EM; Holohan C; Redmond KM; McLaughlin KM; Busacca S; Barbone D; Broaddus VC; Gray SG; O'Byrne KJ; Johnston PG; Fennell DA; Longley DB
Eur J Cancer; 2012 May; 48(7):1096-107. PubMed ID: 22154545
[TBL] [Abstract][Full Text] [Related]
3. HDAC6 deacetylates Ku70 and regulates Ku70-Bax binding in neuroblastoma.
Subramanian C; Jarzembowski JA; Opipari AW; Castle VP; Kwok RP
Neoplasia; 2011 Aug; 13(8):726-34. PubMed ID: 21847364
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonists.
McCann C; Crawford N; Majkut J; Holohan C; Armstrong CWD; Maxwell PJ; Ong CW; LaBonte MJ; McDade SS; Waugh DJ; Longley DB
Cell Death Dis; 2018 Oct; 9(11):1081. PubMed ID: 30349042
[TBL] [Abstract][Full Text] [Related]
5. Ku70 is essential for histone deacetylase inhibitor trichostatin A-induced apoptosis.
Meng J; Zhang F; Zhang XT; Zhang T; Li YH; Fan L; Sun Y; Zhang HL; Mei QB
Mol Med Rep; 2015 Jul; 12(1):581-6. PubMed ID: 25695595
[TBL] [Abstract][Full Text] [Related]
6. Ku70 acetylation and modulation of c-Myc/ATF4/CHOP signaling axis by SIRT1 inhibition lead to sensitization of HepG2 cells to TRAIL through induction of DR5 and down-regulation of c-FLIP.
Kim MJ; Hong KS; Kim HB; Lee SH; Bae JH; Kim DW; Dao TT; Oh WK; Kang CD; Kim SH
Int J Biochem Cell Biol; 2013 Mar; 45(3):711-23. PubMed ID: 23247197
[TBL] [Abstract][Full Text] [Related]
7. Itch/AIP4-independent proteasomal degradation of cFLIP induced by the histone deacetylase inhibitor SAHA sensitizes breast tumour cells to TRAIL.
Yerbes R; López-Rivas A
Invest New Drugs; 2012 Apr; 30(2):541-7. PubMed ID: 21107885
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and therapeutic relevance of c-FLIP in acute myeloid leukaemia.
McLornan D; Hay J; McLaughlin K; Holohan C; Burnett AK; Hills RK; Johnston PG; Mills KI; McMullin MF; Longley DB; Gilkes A
Br J Haematol; 2013 Jan; 160(2):188-98. PubMed ID: 23167276
[TBL] [Abstract][Full Text] [Related]
9. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.
Chen MC; Huang HH; Lai CY; Lin YJ; Liou JP; Lai MJ; Li YH; Teng CM; Yang CR
Oncotarget; 2016 Jan; 7(1):402-17. PubMed ID: 26587975
[TBL] [Abstract][Full Text] [Related]
10. Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells.
You BR; Han BR; Park WH
Oncotarget; 2017 Mar; 8(11):17726-17737. PubMed ID: 28099148
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors sensitize lung cancer cells to hyperthermia: involvement of Ku70/SirT-1 in thermo-protection.
Hassan MK; Watari H; Salah-Eldin AE; Sultan AS; Mohamed Z; Fujioka Y; Ohba Y; Sakuragi N
PLoS One; 2014; 9(4):e94213. PubMed ID: 24728004
[TBL] [Abstract][Full Text] [Related]
12. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
Negmeldin AT; Knoff JR; Pflum MKH
Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
[TBL] [Abstract][Full Text] [Related]
13. Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors.
Subramanian C; Opipari AW; Bian X; Castle VP; Kwok RP
Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4842-7. PubMed ID: 15778293
[TBL] [Abstract][Full Text] [Related]
14. SMAR1 coordinates HDAC6-induced deacetylation of Ku70 and dictates cell fate upon irradiation.
Chaudhary N; Nakka KK; Chavali PL; Bhat J; Chatterjee S; Chattopadhyay S
Cell Death Dis; 2014 Oct; 5(10):e1447. PubMed ID: 25299772
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.
Munshi A; Kurland JF; Nishikawa T; Tanaka T; Hobbs ML; Tucker SL; Ismail S; Stevens C; Meyn RE
Clin Cancer Res; 2005 Jul; 11(13):4912-22. PubMed ID: 16000590
[TBL] [Abstract][Full Text] [Related]
16. SAHA overcomes FLIP-mediated inhibition of SMAC mimetic-induced apoptosis in mesothelioma.
Crawford N; Stasik I; Holohan C; Majkut J; McGrath M; Johnston PG; Chessari G; Ward GA; Waugh DJ; Fennell DA; Longley DB
Cell Death Dis; 2013 Jul; 4(7):e733. PubMed ID: 23868066
[TBL] [Abstract][Full Text] [Related]
17. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci.
Munshi A; Tanaka T; Hobbs ML; Tucker SL; Richon VM; Meyn RE
Mol Cancer Ther; 2006 Aug; 5(8):1967-74. PubMed ID: 16928817
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents.
Namdar M; Perez G; Ngo L; Marks PA
Proc Natl Acad Sci U S A; 2010 Nov; 107(46):20003-8. PubMed ID: 21037108
[TBL] [Abstract][Full Text] [Related]
19. CREB-binding protein is a mediator of neuroblastoma cell death induced by the histone deacetylase inhibitor trichostatin A.
Subramanian C; Jarzembowski JA; Opipari AW; Castle VP; Kwok RP
Neoplasia; 2007 Jun; 9(6):495-503. PubMed ID: 17603632
[TBL] [Abstract][Full Text] [Related]
20. FLIP: A Targetable Mediator of Resistance to Radiation in Non-Small Cell Lung Cancer.
McLaughlin KA; Nemeth Z; Bradley CA; Humphreys L; Stasik I; Fenning C; Majkut J; Higgins C; Crawford N; Holohan C; Johnston PG; Harrison T; Hanna GG; Butterworth KT; Prise KM; Longley DB
Mol Cancer Ther; 2016 Oct; 15(10):2432-2441. PubMed ID: 27474150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
